UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (33091) 33091
Newsletter (644) 644
Magazine Article (245) 245
Book Chapter (78) 78
Newspaper Article (56) 56
Transcript (17) 17
Book / eBook (12) 12
Conference Proceeding (8) 8
Publication (4) 4
Reference (3) 3
Dissertation (2) 2
Government Document (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (27424) 27424
science & technology (19146) 19146
life sciences & biomedicine (18317) 18317
staphylococcal infections - drug therapy (14932) 14932
male (14525) 14525
female (13762) 13762
biological and medical sciences (9342) 9342
anti-bacterial agents - therapeutic use (8888) 8888
medical sciences (8844) 8844
infectious diseases (8632) 8632
staphylococcal infections - microbiology (8508) 8508
adult (8323) 8323
middle aged (8253) 8253
staphylococcus aureus (7610) 7610
aged (6442) 6442
animals (6029) 6029
microbiology (5720) 5720
staphylococcus aureus - drug effects (5297) 5297
bacterial diseases (4664) 4664
microbial sensitivity tests (4497) 4497
staphylococcal infections (4411) 4411
human bacterial diseases (4336) 4336
adolescent (4195) 4195
anti-bacterial agents - pharmacology (4129) 4129
child (4095) 4095
abridged index medicus (4050) 4050
staphylococcal infections - diagnosis (4038) 4038
staphylococcus aureus - isolation & purification (3720) 3720
staphylococcal infections - epidemiology (3597) 3597
methicillin resistance (3530) 3530
staphylococcal infections, streptococcal infections, pneumococcal infections (3367) 3367
health aspects (3325) 3325
antibiotics (3180) 3180
treatment outcome (3173) 3173
pharmacology. drug treatments (2939) 2939
risk factors (2922) 2922
child, preschool (2920) 2920
retrospective studies (2917) 2917
infant (2899) 2899
pharmacology & pharmacy (2895) 2895
staphylococcal infections - complications (2880) 2880
staphylococcal infections - therapy (2874) 2874
staphylococcal infections - etiology (2766) 2766
antibacterial agents (2613) 2613
antibiotics. antiinfectious agents. antiparasitic agents (2593) 2593
anti-bacterial agents - administration & dosage (2470) 2470
staphylococcus aureus infections (2392) 2392
aged, 80 and over (2358) 2358
staphylococcus infections (2316) 2316
methicillin-resistant staphylococcus aureus - drug effects (2293) 2293
methicillin-resistant staphylococcus aureus - isolation & purification (2270) 2270
surgery (2270) 2270
methicillin-resistant staphylococcus aureus (2195) 2195
mice (2178) 2178
drug resistance in microorganisms (2129) 2129
immunology (2101) 2101
infections (2046) 2046
general & internal medicine (1980) 1980
staphylococcal infections - prevention & control (1980) 1980
infant, newborn (1948) 1948
research (1939) 1939
bacteria (1808) 1808
vancomycin - therapeutic use (1808) 1808
drug resistance (1797) 1797
infection (1740) 1740
pediatrics (1691) 1691
care and treatment (1638) 1638
analysis (1603) 1603
time factors (1531) 1531
medicine, general & internal (1487) 1487
streptococcal infections - drug therapy (1454) 1454
prospective studies (1449) 1449
cross infection - microbiology (1389) 1389
bacteremia - microbiology (1383) 1383
research article (1354) 1354
mrsa (1343) 1343
drug therapy (1312) 1312
young adult (1284) 1284
drug resistance, microbial (1250) 1250
disease models, animal (1242) 1242
drug resistance, bacterial (1241) 1241
staphylococcus aureus - genetics (1222) 1222
vancomycin (1212) 1212
bacteremia - drug therapy (1211) 1211
endocarditis, bacterial - drug therapy (1196) 1196
drug therapy, combination (1174) 1174
staphylococcus (1159) 1159
follow-up studies (1153) 1153
nosocomial infections (1139) 1139
staphylococcus - drug effects (1126) 1126
mortality (1124) 1124
cross infection - drug therapy (1105) 1105
staphylococcal infections - surgery (1100) 1100
biochemical phenomena, metabolism, and nutrition (1082) 1082
cross infection - epidemiology (1076) 1076
infectious disease (1076) 1076
methicillin (1071) 1071
incidence (1063) 1063
medical research (1060) 1060
dermatology (1054) 1054
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (29976) 29976
Russian (1066) 1066
French (888) 888
German (861) 861
Japanese (640) 640
Spanish (504) 504
Italian (224) 224
Polish (204) 204
Portuguese (147) 147
Chinese (100) 100
Dutch (88) 88
Danish (82) 82
Czech (63) 63
Romanian (50) 50
Turkish (43) 43
Norwegian (42) 42
Ukrainian (38) 38
Hungarian (33) 33
Swedish (32) 32
Hebrew (21) 21
Finnish (20) 20
Croatian (17) 17
Bulgarian (13) 13
Serbian (10) 10
Korean (7) 7
Slovak (7) 7
Lithuanian (3) 3
Icelandic (2) 2
Arabic (1) 1
Armenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of infectious diseases, ISSN 0022-1899, 11/2014, Volume 210, Issue 9, pp. 1357 - 1366
Biofilms | Antibiotics | Escherichia coli | Bacteria | Aminoglycosides | Pseudomonas aeruginosa | Infections | Basic amino acids | Staphylococcus aureus | aminoglycoside | persister | catheter-related infections | biofilm | proton motive force | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Escherichia coli Infections - prevention & control | Central Venous Catheters - microbiology | Escherichia coli - drug effects | Gentamicins - administration & dosage | Catheter-Related Infections - prevention & control | Pseudomonas Infections - prevention & control | Arginine - administration & dosage | Gentamicins - pharmacology | Drug Therapy, Combination | Biofilms - drug effects | Escherichia coli Infections - drug therapy | Staphylococcal Infections - drug therapy | Pseudomonas Infections - drug therapy | Rats | Central Venous Catheters - adverse effects | Pseudomonas aeruginosa - drug effects | Catheter-Related Infections - drug therapy | Drug Synergism | Animals | Arginine - pharmacology | Staphylococcal Infections - prevention & control | Anti-Bacterial Agents - pharmacology | In Vitro Techniques | Staphylococcus aureus - drug effects | Hydrogen-Ion Concentration | Health aspects | Research | Index Medicus | Abridged Index Medicus | Biofilms/drug effects | Gentamicins/administration & dosage | Anti-Bacterial Agents/pharmacology | Staphylococcal Infections/drug therapy | Arginine/administration & dosage | Life Sciences | Escherichia coli Infections/drug therapy | Staphylococcus aureus/drug effects | Gentamicins/pharmacology | Catheter-Related Infections/prevention & control | Pseudomonas aeruginosa/drug effects | Staphylococcal Infections/prevention & control | Catheter-Related Infections/drug therapy | Central Venous Catheters/microbiology | Escherichia coli/drug effects | Bacteriology | Microbiology and Parasitology | Central Venous Catheters/adverse effects | Arginine/pharmacology | Pseudomonas Infections/prevention & control | Escherichia coli Infections/prevention & control | Pseudomonas Infections/drug therapy
Journal Article
Burns, ISSN 0305-4179, 2016, Volume 43, Issue 3, pp. 642 - 653
Critical Care | Nosocomial infection | Burn wound infection | Pneumonia | Urinary tract infection | Health care related infection | Burns | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Dermatology | Surgery | Science & Technology | Escherichia coli | Humans | Middle Aged | Child, Preschool | Male | Young Adult | Folliculitis - epidemiology | Aged, 80 and over | Urinary Tract Infections - microbiology | Catheter-Related Infections - epidemiology | Child | Infant, Newborn | Staphylococcus aureus | Escherichia coli Infections - drug therapy | Bacteremia - drug therapy | Pseudomonas Infections - microbiology | Wound Infection - epidemiology | Catheter-Related Infections - drug therapy | Drug Resistance, Microbial | Escherichia coli Infections - epidemiology | Acinetobacter baumannii | Catheter-Related Infections - microbiology | Adolescent | Bacteremia - epidemiology | Infant | Bacteremia - microbiology | Cephalosporins - therapeutic use | Anti-Bacterial Agents - therapeutic use | Klebsiella Infections - epidemiology | Adult | Female | Pseudomonas aeruginosa | Staphylococcal Infections - microbiology | Wound Infection - drug therapy | Acinetobacter Infections - microbiology | Staphylococcal Infections - drug therapy | Colombia - epidemiology | Klebsiella Infections - drug therapy | Central Venous Catheters | Pneumonia - epidemiology | Pseudomonas Infections - drug therapy | Acinetobacter Infections - drug therapy | Escherichia coli Infections - microbiology | Folliculitis - microbiology | Pneumonia - microbiology | Klebsiella Infections - microbiology | Oxacillin - therapeutic use | Burns - epidemiology | Urinary Tract Infections - drug therapy | Urinary Tract Infections - epidemiology | Pneumonia - drug therapy | Staphylococcal Infections - epidemiology | Pseudomonas Infections - epidemiology | Acinetobacter Infections - epidemiology | Wound Infection - microbiology | Aged | Folliculitis - drug therapy | Klebsiella pneumoniae | Development and progression | Burns and scalds | Surgery, Plastic | Health aspects | Staphylococcus aureus infections | Analysis | Bacterial pneumonia | Mortality | Urinary tract infections | Bacteria | Disease susceptibility | Antibacterial agents | Index Medicus
Journal Article
American journal of respiratory and critical care medicine, ISSN 1073-449X, 10/2019, Volume 200, Issue 7, pp. E45 - E67
Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Community-Acquired Infections - diagnosis | Culture Techniques | United States | Humans | Pneumonia, Pneumococcal - diagnosis | Haemophilus Infections - diagnosis | Anti-Bacterial Agents - therapeutic use | Community-Acquired Infections - drug therapy | Adult | Haemophilus Infections - metabolism | Drug Therapy, Combination | Haemophilus Infections - drug therapy | Pneumonia, Mycoplasma - metabolism | Severity of Illness Index | Chlamydophila Infections - drug therapy | Blood Culture | Chlamydophila Infections - metabolism | Legionellosis - diagnosis | Hospitalization | Legionellosis - drug therapy | Pneumonia, Bacterial - diagnosis | Ambulatory Care | Moraxellaceae Infections - drug therapy | Chlamydophila Infections - diagnosis | Pneumonia, Pneumococcal - metabolism | Antigens, Bacterial - urine | Pneumonia, Staphylococcal - drug therapy | Moraxellaceae Infections - metabolism | Pneumonia, Staphylococcal - diagnosis | Pneumonia, Staphylococcal - metabolism | Sputum | Pneumonia, Bacterial - drug therapy | Legionellosis - metabolism | Pneumonia, Pneumococcal - drug therapy | Radiography, Thoracic | Moraxellaceae Infections - diagnosis | Macrolides - therapeutic use | beta-Lactams - therapeutic use | Pneumonia, Mycoplasma - diagnosis | Pneumonia, Mycoplasma - drug therapy | Clinical trials | Pneumonia | Adults | Medical diagnosis | Medical treatment | Index Medicus | Abridged Index Medicus | community-acquired pneumonia | American Thoracic Society Documents | pneumonia; patient management
Journal Article
American journal of respiratory and critical care medicine, ISSN 1073-449X, 03/2016, Volume 193, Issue 5, pp. 504 - 515
Healthy controls | Cystic fibrosis | Microbiota | Nasopharynx | Longitudinal | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Carrier State - epidemiology | Streptococcus mitis - genetics | Prospective Studies | Humans | Corynebacterium Infections - epidemiology | Carrier State - microbiology | Haemophilus Infections - epidemiology | Infant | Male | Corynebacterium Infections - microbiology | Case-Control Studies | Anti-Bacterial Agents - therapeutic use | Enterobacteriaceae Infections - epidemiology | Female | Staphylococcal Infections - microbiology | Nasopharynx - microbiology | Real-Time Polymerase Chain Reaction | Burkholderia Infections - microbiology | Haemophilus Infections - drug therapy | Infant, Newborn | Staphylococcus aureus - genetics | Moraxellaceae Infections - epidemiology | Streptococcal Infections - microbiology | Burkholderia - genetics | Staphylococcal Infections - drug therapy | Burkholderia Infections - epidemiology | Cystic Fibrosis - microbiology | Enterobacteriaceae Infections - microbiology | Enterobacteriaceae - genetics | Moraxellaceae Infections - microbiology | Streptococcal Infections - epidemiology | Haemophilus influenzae - genetics | Corynebacterium - genetics | Cystic Fibrosis - epidemiology | Moraxellaceae Infections - drug therapy | DNA, Bacterial - genetics | Staphylococcal Infections - epidemiology | Corynebacterium Infections - drug therapy | Microbiota - genetics | Burkholderia Infections - drug therapy | Haemophilus Infections - microbiology | RNA, Ribosomal, 16S - genetics | Streptococcal Infections - drug therapy | Moraxella - genetics | Cohort Studies | Enterobacteriaceae Infections - drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
European journal of clinical microbiology & infectious diseases, ISSN 0934-9723, 9/2018, Volume 37, Issue 9, pp. 1627 - 1636
Medical Microbiology | Biomedicine | Targeted therapy | Escherichia coli | Bloodstream infections | Internal Medicine | ESKAPE | Antimicrobial resistance | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Escherichia coli - drug effects | Humans | Escherichia coli Infections - blood | Molecular Targeted Therapy | Incidence | Bacteremia - microbiology | Hospitals, Teaching - statistics & numerical data | Anti-Bacterial Agents - therapeutic use | Klebsiella Infections - epidemiology | Drug Resistance, Multiple, Bacterial | Staphylococcal Infections - microbiology | Catheter-Related Infections - epidemiology | Cross Infection - epidemiology | Escherichia coli Infections - drug therapy | Staphylococcal Infections - drug therapy | Klebsiella Infections - drug therapy | Pseudomonas Infections - drug therapy | Methicillin-Resistant Staphylococcus aureus - drug effects | Bacteremia - drug therapy | Escherichia coli Infections - microbiology | beta-Lactamases - drug effects | Klebsiella Infections - microbiology | Pseudomonas Infections - microbiology | Cross Infection - drug therapy | Catheter-Related Infections - drug therapy | Bacterial Proteins - drug effects | Escherichia coli Infections - epidemiology | Staphylococcal Infections - epidemiology | Pseudomonas Infections - epidemiology | Escherichia coli - genetics | Escherichia coli - isolation & purification | Catheter-Related Infections - microbiology | Cross Infection - microbiology | Bacteremia - epidemiology | Anti-Bacterial Agents - pharmacology | Drug resistance in microorganisms | Pneumonia | Bacterial pneumonia | Beta lactamases | Health aspects | Public health | Klebsiella | Health care | Pathogens | Communities | Carbapenemase | Antimicrobial agents | Infections | Drug resistance | Antiinfectives and antibacterials | Methicillin | E coli | Pseudomonas aeruginosa | Bacteria | Meropenem | Trends | Ciprofloxacin | Active control | Emergency medical services | Ceftazidime | Index Medicus
Journal Article
American journal of respiratory and critical care medicine, ISSN 1073-449X, 2001, Volume 163, Issue 6, pp. 1371 - 1375
Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | Medical sciences | Antibacterial agents | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Recurrence | Enterobacteriaceae Infections - diagnosis | Prospective Studies | Humans | Middle Aged | Haemophilus Infections - blood | Male | Pneumococcal Infections - diagnosis | Haemophilus Infections - diagnosis | Pseudomonas Infections - blood | Respiration, Artificial - adverse effects | Time Factors | Pneumonia - diagnosis | Pneumonia - blood | Pneumococcal Infections - etiology | Risk Factors | Enterobacteriaceae Infections - etiology | Pseudomonas Infections - diagnosis | Cross Infection - drug therapy | Pneumococcal Infections - blood | Cross Infection - diagnosis | Bacterial Infections - blood | Cross Infection - blood | Enterobacteriaceae Infections - drug therapy | Practice Guidelines as Topic | Staphylococcal Infections - etiology | Pneumococcal Infections - drug therapy | Pseudomonas Infections - etiology | Cross Infection - etiology | Bacterial Infections - etiology | Infection Control - methods | Haemophilus influenzae | Bronchoalveolar Lavage Fluid - microbiology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Adult | Female | Leukocyte Count | Haemophilus Infections - drug therapy | Staphylococcal Infections - blood | Staphylococcal Infections - drug therapy | Pneumonia - etiology | Pseudomonas Infections - drug therapy | Proportional Hazards Models | Treatment Outcome | Haemophilus Infections - etiology | Staphylococcal Infections - diagnosis | Pneumonia - drug therapy | Enterobacteriaceae Infections - blood | Aged | Bacterial Infections - diagnosis | Drug Monitoring | Index Medicus | Abridged Index Medicus
Journal Article
Clinical orthopaedics and related research, ISSN 0009-921X, 7/2013, Volume 471, Issue 7, pp. 2383 - 2399
Surgical Orthopedics | Medicine & Public Health | Sports Medicine | Orthopedics | Surgery | Conservative Orthopedics | Medicine/Public Health, general | Life Sciences & Biomedicine | Science & Technology | Community-Acquired Infections - diagnosis | Community-Acquired Infections - therapy | Community-Acquired Infections - transmission | Hospital Costs | Cross Infection - economics | Humans | Orthopedic Procedures - adverse effects | Infection Control - methods | Cost Savings | Cross Infection - transmission | Staphylococcal Infections - microbiology | Surgical Wound Infection - transmission | Cross Infection - prevention & control | Mass Screening - economics | Community-Acquired Infections - economics | Surgical Wound Infection - economics | Anti-Infective Agents - therapeutic use | Treatment Outcome | Staphylococcal Infections - therapy | Staphylococcal Infections - transmission | Surgical Wound Infection - prevention & control | Staphylococcal Infections - diagnosis | Staphylococcal Infections - economics | Cost-Benefit Analysis | Cross Infection - microbiology | Surgical Wound Infection - diagnosis | Cross Infection - diagnosis | Orthopedic Procedures - economics | Staphylococcal Infections - prevention & control | Methicillin-Resistant Staphylococcus aureus - isolation & purification | Program Evaluation | Surgical Wound Infection - microbiology | Community-Acquired Infections - microbiology | Infection Control - economics | Online health care information services | Orthopedic surgery | Health aspects | Analysis | Staphylococcal infections | Staphylococcus aureus | Index Medicus | Abridged Index Medicus | Survey
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 9/2015, Volume 61, Issue suppl 2, pp. S69 - S78
Journal Article